Literature DB >> 24044030

Use of Ultrasonic Bone Surgery (Piezosurgery) to Surgically Treat Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ). A Case Series Report with at Least 1 Year of Follow-Up.

Cornelio Blus1, Serge Szmukler-Moncler, Giulio Giannelli, Gloria Denotti, Germano Orrù.   

Abstract

This preliminary work documents the use of a powerful piezosurgery device to treat biphosphonate-related osteonecrosis of the jaw (BRONJ) in combination with classical medication therapy. Eight patients presenting 9 BRONJ sites were treated, 2 in the maxilla and 7 in the mandible. Reason for biphosphonate (BiP) intake was treatment of an oncologic disease for 5 patients and osteoporosis for 3. The oncologic and osteoporosis patients were diagnosed with BRONJ after 35-110 months and 80-183 months of BiP treatment, respectively. BRONJ 2 and 3 was found in 4 patients. Resection of the bone sequestrae was performed with a high power ultrasonic (piezo) surgery and antibiotics were administrated for 2 weeks. Soft tissue healing was incomplete at the 2-week control but it was achieved within 1 month. At the 1-year control, soft tissue healing was maintained at all patients, without symptom recurrence. One patient with paraesthesia had abated; of the 2 pa-tients with trismus, one was healed, severity of the second trismus abated. This case report series suggests that bone resection performed with a high power ultrasonic surgery device combined with antibiotics might lead to BRONJ healing. More patients are warranted to confirm the present findings and assess this treatment approach.

Entities:  

Keywords:  BRONJ; Biofilm; Bisphosphonates; Bone infection; ONJ.; Osteonecrosis; Piezosurgery; Ultrasonic bone surgery

Year:  2013        PMID: 24044030      PMCID: PMC3772575          DOI: 10.2174/1874210601307010094

Source DB:  PubMed          Journal:  Open Dent J        ISSN: 1874-2106


  32 in total

1.  A prospective clinical trial for assessing the efficacy of a minimally invasive protocol in patients with bisphosphonate-associated osteonecrosis of the jaws.

Authors:  Filippo Moretti; Gian Andrea Pelliccioni; Lucio Montebugnoli; Claudio Marchetti
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2011-10-14

Review 2.  Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients.

Authors:  Paolo Vescovi; Elisabetta Merigo; Marco Meleti; Maddalena Manfredi; Rebecca Guidotti; Samir Nammour
Journal:  J Oral Pathol Med       Date:  2011-09-30       Impact factor: 4.253

3.  Sinus bone grafting procedures using ultrasonic bone surgery: 5-year experience.

Authors:  Cornelio Blus; Serge Szmukler-Moncler; Maurice Salama; Henry Salama; David Garber
Journal:  Int J Periodontics Restorative Dent       Date:  2008-06       Impact factor: 1.840

4.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra
Journal:  Aust Endod J       Date:  2009-12       Impact factor: 1.659

5.  Long-term prevention of skeletal complications of metastatic breast cancer with pamidronate. Protocol 19 Aredia Breast Cancer Study Group.

Authors:  G N Hortobagyi; R L Theriault; A Lipton; L Porter; D Blayney; C Sinoff; H Wheeler; J F Simeone; J J Seaman; R D Knight; M Heffernan; K Mellars; D J Reitsma
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

6.  American Society of Clinical Oncology clinical practice guidelines: the role of bisphosphonates in multiple myeloma.

Authors:  James R Berenson; Bruce E Hillner; Robert A Kyle; Ken Anderson; Allan Lipton; Gary C Yee; J Sybil Biermann
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

7.  Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial.

Authors:  Lee S Rosen; David Gordon; N Simon Tchekmedyian; Ronald Yanagihara; Vera Hirsh; Maciej Krzakowski; Marek Pawlicki; Paul De Souza; Ming Zheng; Gladys Urbanowitz; Dirk Reitsma; John Seaman
Journal:  Cancer       Date:  2004-06-15       Impact factor: 6.860

8.  Cytokines and growth factors involved in the osseointegration of oral titanium implants positioned using piezoelectric bone surgery versus a drill technique: a pilot study in minipigs.

Authors:  Giulio Preti; Germana Martinasso; Bruno Peirone; Roberto Navone; Carlo Manzella; Giuliana Muzio; Crescenzo Russo; Rosa A Canuto; Gianmario Schierano
Journal:  J Periodontol       Date:  2007-04       Impact factor: 6.993

9.  Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.

Authors:  David C Stanton; Edward Balasanian
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

10.  Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases.

Authors:  Paolo Vescovi; Elisabetta Merigo; Maddalena Manfredi; Marco Meleti; Carlo Fornaini; Mauro Bonanini; Jean Paul Rocca; Samir Nammour
Journal:  Photomed Laser Surg       Date:  2008-02       Impact factor: 2.796

View more
  9 in total

1.  Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws.

Authors:  Elisabetta Merigo; Luigi Cella; Aldo Oppici; Maria Cristina Arbasi; Fabio Clini; Matteo Fontana; Carlo Fornaini
Journal:  J Lasers Med Sci       Date:  2018-03-20

2.  The influence of geranylgeraniol on microvessel sprouting after bisphosphonate substitution in an in vitro 3D-angiogenesis assay.

Authors:  A M Pabst; M Krüger; K Sagheb; T Ziebart; C Jacobs; S Blatt; E Goetze; C Walter
Journal:  Clin Oral Investig       Date:  2016-05-12       Impact factor: 3.573

Review 3.  Surgical management of bisphosphonate-related osteonecrosis of the jaws: literature review.

Authors:  Larissa Fernandes Silva; Cláudia Curra; Marcelo Salles Munerato; Carlos Cesar Deantoni; Mariza Akemi Matsumoto; Camila Lopes Cardoso; Marcos Martins Curi
Journal:  Oral Maxillofac Surg       Date:  2015-12-11

4.  Analysis of reasons for osteonecrosis of the jaws.

Authors:  Christian Walter; Keyvan Sagheb; Jennifer Bitzer; Roman Rahimi-Nedjat; Katherine Joyce Taylor
Journal:  Clin Oral Investig       Date:  2014-02-18       Impact factor: 3.573

Review 5.  Analysis of different therapeutic protocols for osteonecrosis of the jaw associated with oral and intravenous bisphosphonates.

Authors:  E-B Bermúdez-Bejarano; M-Á Serrera-Figallo; A Gutiérrez-Corrales; M-M Romero-Ruiz; R Castillo-de-Oyagüe; J-L Gutiérrez-Pérez; G Machuca-Portillo; D Torres-Lagares
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-01-01

6.  Complementarity of Photo-Biomodulation, Surgical Treatment, and Antibiotherapy for Medication-Related Osteonecrosis of the Jaws (MRONJ).

Authors:  Diana Florina Nica; Mircea Riviș; Ciprian Ioan Roi; Carmen Darinca Todea; Virgil-Florin Duma; Cosmin Sinescu
Journal:  Medicina (Kaunas)       Date:  2021-02-05       Impact factor: 2.430

7.  Treatment of Stage 2 Medication-Induced Osteonecrosis of the Jaw: A Case Series.

Authors:  Guillermo Pardo-Zamora; Yanet Martínez; Jose Antonio Moreno; Antonio J Ortiz-Ruíz
Journal:  Int J Environ Res Public Health       Date:  2021-01-24       Impact factor: 3.390

8.  Treatment of medication-related osteonecrosis of the jaws (MRONJ) with ultrasonic piezoelectric bone surgery. A case series of 20 treated sites.

Authors:  Cornelio Blus; Giulio Giannelli; Serge Szmukler-Moncler; Germano Orru
Journal:  Oral Maxillofac Surg       Date:  2016-12-06

9.  New dimensional staging of bisphosphonate-related osteonecrosis of the jaw allowing a guided surgical treatment protocol: long-term follow-up of 266 lesions in neoplastic and osteoporotic patients from the university of bari.

Authors:  Simonetta Franco; Simona Miccoli; Luisa Limongelli; Angela Tempesta; Giorgio Favia; Eugenio Maiorano; Gianfranco Favia
Journal:  Int J Dent       Date:  2014-06-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.